Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PG | UL |
|---|---|---|
| Price | $146.98 | $62.24 |
| Change today | ▼ 0.28% | ▲ 0.13% |
| Market cap | $341.39B | $134.02B |
| Return, 3 months | -2.6% | +4.7% |
| Return, year to date | +4.8% | -2.4% |
| Return, 1 year | -0.7% | -4.7% |
| P/E (TTM) | 22.2 | 12.9 |
| P/B | 6.4 | 7.3 |
| P/E percentile vs own 5y | 14th | 8th |
| Dividend yield | 2.90% | 3.58% |
| Revenue growth (YoY, latest qtr) | +1.5% | +12.0% |
| Net profit growth (YoY) | -15.0% | +15.0% |
| Gross margin | 50.2% | – |
| Operating margin | 22.7% | 20.2% |
| Net margin | 18.1% | 18.3% |
| Return on equity | 30.1% | 54.6% |
| Analyst target vs. price | +9.4% | +22.1% |
| Analyst buy share | 56% | 100% |
| RSI (14) | 58 | 48 |
| 30-day volatility | 13.8% | 18.0% |
| Max drawdown, 1 year | -15.5% | -25.1% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.